These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10717600)

  • 1. Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers.
    Simonsen AC; Sørensen H
    Vox Sang; 1999; 77(4):210-7. PubMed ID: 10717600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
    Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A
    Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
    Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
    Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.
    Zeiler T; Riess H; Wittmann G; Hintz G; Zimmermann R; Müller C; Heuft HG; Huhn D
    Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
    Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
    Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.
    Álvarez M; Luis-Hidalgo M; Bracho MA; Blanquer A; Larrea L; Villalba J; Puig N; Planelles D; Montoro J; González-Candelas F; Roig R
    Transfusion; 2016 Apr; 56(4):831-6. PubMed ID: 26585542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study].
    Wieding JU; Neumeyer H
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience.
    Politis C; Kavallierou L; Hantziara S; Parara M; Zervou E; Katsarou O; Hatzitaki M; Fountouli P; Gioka A; Tzioura K; Koumarianos S; Asariotou M; Richardson C
    Transfus Med; 2014 Oct; 24(5):316-20. PubMed ID: 25262924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma.
    Garwood M; Cardigan RA; Drummond O; Hornsey VS; Turner CP; Young D; Williamson LM; Prowse CV
    Transfusion; 2003 Sep; 43(9):1238-47. PubMed ID: 12919426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
    Moog R; Reichenberg S; Hoburg A; Müller N
    Transfusion; 2010 Feb; 50(2):516-8. PubMed ID: 20233360
    [No Abstract]   [Full Text] [Related]  

  • 12. A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
    Heger A; Römisch J; Svae TE
    Transfus Apher Sci; 2006 Dec; 35(3):223-33. PubMed ID: 17118709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.
    Thiele T; Hron G; Kellner S; Wasner C; Westphal A; Warkentin TE; Greinacher A; Selleng K
    Blood Transfus; 2016 Jan; 14(1):66-72. PubMed ID: 26192785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate.
    Backholer L; Wiltshire M; Proffitt S; Cookson P; Cardigan R
    Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system.
    Abe H; Yamada-Ohnishi Y; Hirayama J; Owada T; Ikeda H; Ikebuchi K
    Transfusion; 2000 Sep; 40(9):1081-7. PubMed ID: 10988311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylene blue-treated plasma on red cells and stored platelet concentrates.
    Perrotta PL; Baril L; Tead C; Chapman J; Dincecco D; Buchholz DH; Snyder EL
    Transfusion; 1999 Jan; 39(1):63-9. PubMed ID: 9920168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus inactivation of plasma].
    Schmitt H; Mohr H; Lambrecht B; Knüver-Hopf J
    Beitr Infusionsther; 1991; 28():82-91. PubMed ID: 1725665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Important laboratory parameters of deep frozen coagulation active fresh plasma and virus inactivated lyophilized pool plasma].
    Hügler P; Möller JH; Neumann H; Sirtl C; Laubenthal H
    Beitr Infusionsther; 1991; 28():110-4. PubMed ID: 1725607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.